Review of the Most Relevant Cardiac Surgery Articles of 2022: Overview Following the Conclusion of 2023
Review article from Thoracic and Cardiovascular Surgeon that revisits the most relevant articles published in 2022 in the field of cardiac surgery.
Type I Thoracoabdominal Aneurysms Associated with Heritable Aortic Disease: Does Open Repair Remain the Preferred Approach for This Patient Group?
This retrospective study included 992 patients with Crawford type I thoracoabdominal aortic aneurysms who underwent open repair, focusing on outcomes for those with heritable thoracic aortic disease (HTAD).
Disproportion in weight during neonatal transplantation: infants can handle almost anything
This retrospective study reviews data from the United States Organ Procurement and Transplant Network, comparing waitlist times, complication rates, and survival outcomes in infants under one year of age transplanted with a donor-to-recipient weight ratio (DRWR) >2 versus others.
Central Aortic Cannulation in Type A Aortic Dissection Surgery: An Effective and Safe Method?
This study assesses the impact of central versus peripheral aortic cannulation on the outcomes of surgical repair of acute type A aortic dissection.
Novoseven® in cardiac surgery hemostasis: the seventh cavalry
A review article on postoperative outcomes of Novoseven® applied for controlling refractory bleeding after aortic surgery.
Competitive sports and congenital heart disease
Comparison of guidelines from various American and European scientific societies regarding participation in competitive sports among patients with congenital heart disease.
Malperfusion in Type A Aortic Dissection: Solve it…, and solve it quickly
Single-center study of the experience at the University of Pittsburgh Medical Center describing their approach to Type A aortic dissection focused on minimizing complications of cerebral and peripheral malperfusion.
Current Status and Advances in Long-Term Ventricular Assistance
This JACC scientific statement summarizes the progress and challenges of durable ventricular assist devices (VADs) for patients with advanced heart failure, contextualizing current therapy and outcomes, and discussing future technology and priorities.
